Market Overview:
The global naloxone spray market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of opioid overdose, rising awareness about naloxone and its benefits, and the growing number of initiatives by governments and non-profit organizations to increase access to naloxone. Based on type, the global naloxone spray market can be segmented into 2 mg/actuation and 4 mg/actuation. The 2 mg/actuation segment is expected to account for a larger share of the market than the 4 mg/actuation segment during the forecast period. This can be attributed to its lower price point as compared with 4 mg/actuation products. Based on application, hospitals are expected to account for a larger share of the global naloxone spray market than clinics duringthe forecast period.
Product Definition:
Naloxone is a drug used to reverse the effects of an opioid overdose. It blocks the effects of opioids and can quickly restore normal breathing in someone who has stopped breathing due to an overdose. Naloxone is especially important for people who use opioids with other drugs, such as alcohol or benzodiazepines, because these combinations can be particularly deadly.
2 Mg/Actuation:
2Mg/actuation is the estimated amount of force required to deliver a dose of naloxone (opioid antagonist) in an actuation system. It's units are Milligrams per Actuation (mg/act). The 2 mg/actuations strength has been used for more than two decades as the standard measure for opioid antagonists in nasal spray formulations.
4 Mg/Actuation:
4 MG/actuation is the amount of naloxone in a single actuation of Naloxone spray. The standard size nasal spray contains 0.4 mg of naloxone and comes in the form of pre-filled syringes or auto-injectors that are easy to use.
Application Insights:
Based on application, the global naloxone spray market has been segmented into hospitals, clinics, retail pharmacies, online pharmacies and others. The hospitals segment dominated the overall market in terms of revenue in 2017. Hospitals are considered to be the most appropriate settings for opioid overdose treatment as they have a large number of patients suffering from drug dependency and are likely to have more knowledge about such cases which further supports its demand at this time.
The clinics application is anticipated to witness significant growth over the forecast period due to increasing awareness among general practitioners regarding substance abuse and growing incidences of drug-related diseases such as HIV/AIDS and tuberculosis across various regions globally. Moreover, public health authorities often recommend that people who use drugs should be referred by their doctors for treatment at specialized centers which further boosts its consumption at this time point in order to treat these conditions effectively.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of opioid users and high demand for naloxone. The region is expected to maintain its dominance over the forecast period due to increasing cases of opioid-related disorders, growing awareness about these products, and availability of a wide network of pharmacies that carry these products.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising cases related with drug abuse in emerging economies such as China & India. In addition, government initiatives coupled with increasing public awareness are anticipated boost regional growth during the estimated time span.
Growth Factors:
- Increasing incidences of opioid overdose: The increasing incidence of opioid overdose is one of the key growth drivers for the naloxone spray market. According to a study by the National Institute on Drug Abuse, in 2015, around 33,091 people died due to an opioid overdose in the U.S., which was a record high. This number is expected to rise in the coming years owing to the increasing abuse of opioids such as heroin and fentanyl.
- Growing awareness about naloxone spray: The growing awareness about naloxone spray among healthcare professionals and general population is another major growth driver for this market. Naloxone has been shown to be effective in reversing an opioid overdose and hence it is being increasingly used by first responders such as paramedics and police officers during an emergency situation involving an opioid overdose victim.
- Availability of generic versions: The availability of generic versions of naloxone spray has helped reduce its cost significantly over the past few years, making it more affordable for healthcare providers as well as patients/consumers alike.. This is likely to boost demand for this product in coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Naloxone Spray Market Research Report
By Type
2 Mg/Actuation, 4 Mg/Actuation
By Application
Hospitals, Clinics, Retail Pharmacies, Online, Others
By Companies
Teva Pharmaceutical Industries Ltd., Emergent BioSolutions Inc., Teva Pharmaceutical Industries Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Naloxone Spray Market Report Segments:
The global Naloxone Spray market is segmented on the basis of:
Types
2 Mg/Actuation, 4 Mg/Actuation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Retail Pharmacies, Online, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries Ltd.
- Emergent BioSolutions Inc.
- Teva Pharmaceutical Industries Ltd.
Highlights of The Naloxone Spray Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2 Mg/Actuation
- 4 Mg/Actuation
- By Application:
- Hospitals
- Clinics
- Retail Pharmacies
- Online
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Naloxone Spray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Naloxone is a medication that can reverse the effects of an opioid overdose. It is usually given as an injection, but it can also be sprayed into the air.
Some of the major players in the naloxone spray market are Teva Pharmaceutical Industries Ltd., Emergent BioSolutions Inc., Teva Pharmaceutical Industries Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Naloxone Spray Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Naloxone Spray Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Naloxone Spray Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Naloxone Spray Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Naloxone Spray Market Size & Forecast, 2018-2028 4.5.1 Naloxone Spray Market Size and Y-o-Y Growth 4.5.2 Naloxone Spray Market Absolute $ Opportunity
Chapter 5 Global Naloxone Spray Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Naloxone Spray Market Size Forecast by Type
5.2.1 2 Mg/Actuation
5.2.2 4 Mg/Actuation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Naloxone Spray Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Naloxone Spray Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Retail Pharmacies
6.2.4 Online
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Naloxone Spray Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Naloxone Spray Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Naloxone Spray Analysis and Forecast
9.1 Introduction
9.2 North America Naloxone Spray Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Naloxone Spray Market Size Forecast by Type
9.6.1 2 Mg/Actuation
9.6.2 4 Mg/Actuation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Naloxone Spray Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Retail Pharmacies
9.10.4 Online
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Naloxone Spray Analysis and Forecast
10.1 Introduction
10.2 Europe Naloxone Spray Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Naloxone Spray Market Size Forecast by Type
10.6.1 2 Mg/Actuation
10.6.2 4 Mg/Actuation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Naloxone Spray Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Retail Pharmacies
10.10.4 Online
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Naloxone Spray Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Naloxone Spray Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Naloxone Spray Market Size Forecast by Type
11.6.1 2 Mg/Actuation
11.6.2 4 Mg/Actuation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Naloxone Spray Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Retail Pharmacies
11.10.4 Online
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Naloxone Spray Analysis and Forecast
12.1 Introduction
12.2 Latin America Naloxone Spray Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Naloxone Spray Market Size Forecast by Type
12.6.1 2 Mg/Actuation
12.6.2 4 Mg/Actuation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Naloxone Spray Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Retail Pharmacies
12.10.4 Online
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Naloxone Spray Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Naloxone Spray Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Naloxone Spray Market Size Forecast by Type
13.6.1 2 Mg/Actuation
13.6.2 4 Mg/Actuation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Naloxone Spray Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Retail Pharmacies
13.10.4 Online
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Naloxone Spray Market: Competitive Dashboard
14.2 Global Naloxone Spray Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceutical Industries Ltd.
14.3.2 Emergent BioSolutions Inc.
14.3.3 Teva Pharmaceutical Industries Ltd.